Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Department of Gastroenterological Surgery, Oslo University Hospital, Ullevål, Norway.
BMC Cancer. 2017 Jan 30;17(1):83. doi: 10.1186/s12885-017-3072-4.
Colorectal cancer survivors are not only at risk for recurrent disease but also at increased risk of comorbidities such as other cancers, cardiovascular disease, diabetes, hypertension and functional decline. In this trial, we aim at investigating whether a diet in accordance with the Norwegian food-based dietary guidelines and focusing at dampening inflammation and oxidative stress will improve long-term disease outcomes and survival in colorectal cancer patients.
METHODS/DESIGN: This paper presents the study protocol of the Norwegian Dietary Guidelines and Colorectal Cancer Survival study. Men and women aged 50-80 years diagnosed with primary invasive colorectal cancer (Stage I-III) are invited to this randomized controlled, parallel two-arm trial 2-9 months after curative surgery. The intervention group (n = 250) receives an intensive dietary intervention lasting for 12 months and a subsequent maintenance intervention for 14 years. The control group (n = 250) receives no dietary intervention other than standard clinical care. Both groups are offered equal general advice of physical activity. Patients are followed-up at 6 months and 1, 3, 5, 7, 10 and 15 years after baseline. The study center is located at the Department of Nutrition, University of Oslo, and patients are recruited from two hospitals within the South-Eastern Norway Regional Health Authority. Primary outcomes are disease-free survival and overall survival. Secondary outcomes are time to recurrence, cardiovascular disease-free survival, compliance to the dietary recommendations and the effects of the intervention on new comorbidities, intermediate biomarkers, nutrition status, physical activity, physical function and quality of life.
The current study is designed to gain a better understanding of the role of a healthy diet aimed at dampening inflammation and oxidative stress on long-term disease outcomes and survival in colorectal cancer patients. Since previous research on the role of diet for colorectal cancer survivors is limited, the study may be of great importance for this cancer population.
ClinicalTrials.gov Identifier: NCT01570010 .
结直肠癌幸存者不仅有复发疾病的风险,而且还面临其他合并症的风险增加,如其他癌症、心血管疾病、糖尿病、高血压和功能下降。在这项试验中,我们旨在研究遵循挪威基于食物的饮食指南并专注于减轻炎症和氧化应激的饮食是否会改善结直肠癌患者的长期疾病结局和生存。
方法/设计:本文介绍了挪威饮食指南与结直肠癌生存研究的研究方案。年龄在 50-80 岁之间、经确诊患有原发性侵袭性结直肠癌(I-III 期)的男性和女性受邀参加这项随机对照、平行双臂试验,时间为根治性手术后 2-9 个月。干预组(n=250)接受为期 12 个月的强化饮食干预和随后 14 年的维持干预。对照组(n=250)除了标准的临床护理外,不接受任何饮食干预。两组都接受同等的一般体力活动建议。患者在基线后 6 个月和 1、3、5、7、10 和 15 年进行随访。研究中心位于奥斯陆大学营养系,患者招募自东南挪威地区卫生当局的两家医院。主要结局是无病生存和总生存。次要结局是复发时间、无心血管疾病生存、对饮食建议的依从性以及干预对新合并症、中间生物标志物、营养状况、体力活动、身体功能和生活质量的影响。
目前的研究旨在更好地了解针对减轻炎症和氧化应激的健康饮食对结直肠癌患者长期疾病结局和生存的作用。由于之前关于饮食对结直肠癌幸存者作用的研究有限,因此该研究对这一癌症人群可能具有重要意义。
ClinicalTrials.gov 标识符:NCT01570010。